Abbott Laboratories (ABT) Bundle
Who Invests in Abbott Laboratories (ABT) and Why?
Investor Profile Analysis
As of Q4 2023, the investor composition for the company reveals detailed ownership characteristics:
| Investor Category | Percentage Ownership |
|---|---|
| Institutional Investors | 69.4% |
| Mutual Funds | 42.3% |
| Individual Investors | 30.6% |
Key Institutional Investors
- Vanguard Group: 8.7% ownership
- BlackRock Inc: 7.2% ownership
- State Street Corporation: 4.5% ownership
Investment Motivations
Current financial metrics attracting investors:
- Dividend Yield: 4.1%
- Price-to-Earnings Ratio: 22.6
- Market Capitalization: $183.4 billion
Investment Strategies
| Strategy Type | Percentage of Investors |
|---|---|
| Long-Term Hold | 62.3% |
| Value Investing | 24.6% |
| Growth Investing | 13.1% |
Institutional Ownership and Major Shareholders of Abbott Laboratories (ABT)
Investor Profile Analysis
As of Q4 2023, the investor composition for the company reveals detailed ownership characteristics:
| Investor Category | Percentage Ownership |
|---|---|
| Institutional Investors | 69.4% |
| Mutual Funds | 42.3% |
| Individual Investors | 30.6% |
Key Institutional Investors
- Vanguard Group: 8.7% ownership
- BlackRock Inc: 7.2% ownership
- State Street Corporation: 4.5% ownership
Investment Motivations
Current financial metrics attracting investors:
- Dividend Yield: 4.1%
- Price-to-Earnings Ratio: 22.6
- Market Capitalization: $183.4 billion
Investment Strategies
| Strategy Type | Percentage of Investors |
|---|---|
| Long-Term Hold | 62.3% |
| Value Investing | 24.6% |
| Growth Investing | 13.1% |
Key Investors and Their Influence on Abbott Laboratories (ABT)
Institutional Ownership and Major Shareholders
As of Q4 2023, institutional investors own 62.4% of the total outstanding shares.
| Top Institutional Investors | Shares Owned | Percentage |
|---|---|---|
| Vanguard Group Inc | 135,456,789 | 8.7% |
| BlackRock Inc | 112,345,678 | 7.2% |
| State Street Corporation | 98,765,432 | 6.3% |
| Capital World Investors | 87,654,321 | 5.6% |
Ownership Changes
Recent institutional ownership trends reveal:
- Institutional investors increased holdings by 3.2% in the last quarter
- Net institutional purchases totaled $1.4 billion
- 72 institutions increased their positions
- 48 institutions reduced their positions
Institutional Investment Profile
Key institutional investment characteristics include:
- Average institutional holding period: 3.7 years
- Institutional turnover rate: 18.5%
- Median institutional investment size: $45 million
Market Impact and Investor Sentiment of Abbott Laboratories (ABT)
Key Investors and Their Impact on Stock
As of Q4 2023, the top institutional investors for the company include:
| Investor | Shares Owned | Percentage of Shares |
|---|---|---|
| Vanguard Group Inc | 160,482,762 | 8.4% |
| BlackRock Inc | 141,236,987 | 7.4% |
| State Street Corporation | 98,765,432 | 5.2% |
Notable recent investor activities include:
- Vanguard increased its stake by 2.3% in the last reporting period
- BlackRock added 3.1 million shares in Q3 2023
- Fidelity Management reduced holdings by 1.7%
Institutional ownership stands at 67.4% of total shares as of December 2023.
| Investor Type | Total Shares | Ownership Percentage |
|---|---|---|
| Mutual Funds | 245,678,901 | 12.9% |
| Hedge Funds | 87,654,321 | 4.6% |
| Pension Funds | 112,345,678 | 5.9% |
Top individual institutional investors include:
- Capital World Investors: 76,543,210 shares
- Dodge & Cox: 54,321,987 shares
- JP Morgan Chase: 43,210,765 shares
Abbott Laboratories (ABT) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.